(Q40422302)

20 September 2017

title

Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancer (English)

1 reference

20 September 2017

Kuo-Ting Chang

1

1 reference

20 September 2017

Chi-Ying F Huang

2

1 reference

20 September 2017

Chun-Ming Tsai

3

1 reference

20 September 2017

Chao-Hua Chiu

4

1 reference

20 September 2017

Ying-Yung Lok

5

1 reference

20 September 2017

publication date

13 May 2005

1 reference

American Journal of Physiology - Lung Cellular and Molecular Physiology

20 September 2017

published in

1 reference

20 September 2017

volume

289

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

L438-45

1 reference

Neuroendocrine differentiation in prostatic carcinoma

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Neuroendocrine carcinomas of the colon and rectum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Three weeks of caloric restriction alters protein metabolism in normal-weight, young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Interleukin-6 is an autocrine growth factor in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Biologic and molecular prognostic factors--impact on treatment of patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Serum levels of interleukin 6 in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Neuroendocrine differentiated carcinomas of the breast: a distinct entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00033.2005

10.1152/AJPLUNG.00033.2005

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference